NCT02965612

Specific Immunotherapy for Allergic Child

Tolerability and Side Effects for a New Device in Specific Immunotherapy for Allergic Child

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Mariella Enoc · Academic / Other
• Sex: All
• Age: 5 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The recent interest that the Specific Immunotherapy (ITS) has aroused is due to the positive potential role that could be played, in particular in the forms of allergic asthma, because this method constitute the only intervention (unlike that pharmacologic) able to act on the same causes of the disease, altering the natural history. To achieve this the investigator has tried to use the specific subcutaneous immunotherapy (SCIT), to which there are studies that, with scientific rigor, have demonstrated the benefits.

Detailed description

The Investigator proposes to compare, in children with allergic rhinitis and / or allergic asthma to grasses, the pain caused by the administration of the Specific Immunotherapy (ITS) via epicutaneous with autoinjector (INJEX) pressure without needle vs. the traditional subcutaneous immunotherapy (SCIT).

Conditions

• Allergic Rhinitis
• Allergic Asthma
• Grass Allergy

Interventions

Type	Name	Description
DEVICE	Injex	administration of Specific Immunotherapy (ITS) with car pressure injector without a needle
PROCEDURE	SCIT	administration of Specific Immunotherapy (ITS) via traditional subcutaneous

Timeline

• Start date: 2015-05-01
• Primary completion: 2016-12-01
• Completion: 2017-05-01
• First posted: 2016-11-17
• Last updated: 2016-11-17

Locations

1 site across 1 country: Italy